Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Financial Projections for International Money Express in 2024

Elaine Mendonca by Elaine Mendonca
February 27, 2024
in Breaking News
0
Finances-and-tech
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

International Money Express (IntL Money Express) has outlined its financial projections for the first quarter and full year of 2024. The company anticipates the following figures:

Full-year 2024:
– Revenue is estimated to be between $681.0 million and $701.8 million.
– Diluted EPS is forecasted to range from $1.81 to $1.96.
– Adjusted EBITDA is expected to be in the range of $124.0 million to $127.7 million.
– Adjusted Diluted EPS is projected to be between $2.13 and $2.31.

First quarter 2024:
– Revenue is projected to be in the range of $150.4 million to $155.0 million.
– Diluted EPS is expected to be between $0.32 and $0.35.
– Adjusted EBITDA is forecasted to range from $24.4 million to $25.1 million.
– Adjusted Diluted EPS is estimated to be between $0.39 and $0.42.

Overall, International Money Express is optimistic about its financial performance for the year ahead.

IMXI Stock Plummets 9.86% in One Day: Can It Recover?

IMXI stock had a rough day on February 27, 2024, as it experienced a significant drop in price. The stock opened at $19.90, which was $1.60 lower than its previous close. Throughout the day, the price of IMXI shares continued to decrease, ending the day at $17.78. This marked a $2.12 drop from the previous close, representing a 9.86% decrease in value.

Investors and analysts may be watching closely to see if IMXI can reverse this downward trend and start to show some positive momentum. It will be important to monitor the stock’s performance in the coming days and weeks to see if it can recover from this significant drop in price.

IMXI Stock Reports Positive Financial Results for Past Year and Q3 2024

IMXI stock had a mixed performance on February 27, 2024, as the company reported its financial results for the past year and the third quarter. According to data from CNN Money, IMXI’s total revenue for the past year was $473.88 million, which represented a 19.56% increase compared to the previous year. Net income for the past year was $57.33 million, showing a 22.39% increase compared to the previous year. Earnings per share (EPS) for the past year were $1.48, showing a 23.91% increase compared to the previous year. Overall, IMXI’s financial performance showed positive growth in terms of total revenue, net income, and EPS compared to the previous year. Investors may want to closely monitor IMXI’s performance in the coming quarters to assess its future growth potential.

Tags: IMXI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Food Producers Trading online

Portillos Projects Significant Growth in Restaurant Units and Revenue

Data-security

Expansion of SOBR Safe Inc in Canada through Strategic Partnership with TrTek Monitoring Services

Technology Data analytics stock Trading (1)

Revolutionizing Ad Monetization Brightcove and Google Ad Manager Join Forces

Recommended

C3.ai Stock

C3.ai Shares Plunge Amid Mounting Challenges

2 weeks ago
Deutsche Bank Stock

Deutsche Bank Faces Critical Weekend with Dual Operational and Market Challenges

1 month ago
Airbnb Stock

Insider Selling and Institutional Uncertainty Cloud Airbnb’s Outlook

1 month ago
BioNTech Stock

Why BioNTech’s Strong Clinical Data Fails to Impress the Market

1 week ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Strong Earnings and Mixed Signals: Horace Mann Educators’ Q2 Performance

QuantumScape Shares Defy Insider Selling With Major Weekly Rally

Lockheed Martin’s Vectis: A New Era in Unmanned Aerial Combat

Dynex Capital’s Dividend Sustainability Questioned Amid Massive Payout Ratio

Pfizer’s Strategic Gambit: A $7.3 Billion Entry into the Weight-Loss Arena

Nike Shares Face Critical Earnings Test

Trending

Maravai LifeSciences Holdings Registered (A) Stock
Analysis

Is There Any Hope Left for Maravai LifeSciences Investors?

by Dieter Jaworski
September 22, 2025
0

Maravai LifeSciences Holdings Registered (A) shares continue their relentless downward trajectory, leaving shareholders to question whether a...

G III Apparel Stock

G-III Apparel Shares Face Significant Headwinds Following Disappointing Earnings

September 22, 2025
Infinera Stock

Nokia Finalizes Landmark $2.3 Billion Acquisition of Infinera

September 22, 2025
Horace Mann Educators Stock

Strong Earnings and Mixed Signals: Horace Mann Educators’ Q2 Performance

September 22, 2025
QuantumScape Stock

QuantumScape Shares Defy Insider Selling With Major Weekly Rally

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Is There Any Hope Left for Maravai LifeSciences Investors?
  • G-III Apparel Shares Face Significant Headwinds Following Disappointing Earnings
  • Nokia Finalizes Landmark $2.3 Billion Acquisition of Infinera

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com